Individualized Adaptive De-escalated Radiotherapy for HPV-related

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04444869` - Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer	Phase 2
Completed	`NCT00158678` - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC	Phase 3
Completed	`NCT04567082` - Proteome- and Methylation Profiles in Oropharyngeal Cancer
Recruiting	`NCT06016699` - Immunological Function After Radiation With Either Proton or Photon Therapy
Withdrawn	`NCT04001413` - Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients	Phase 2
Completed	`NCT03435471` - Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer	N/A
Completed	`NCT05055206` - Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers	N/A
Recruiting	`NCT04359199` - QUantitative Assessment of Swallowing After Radiation (QUASAR)
Recruiting	`NCT05793151` - Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy	N/A
Active, not recruiting	`NCT02908477` - Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer	Phase 3
Active, not recruiting	`NCT00232960` - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC	N/A
Completed	`NCT05698667` - Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer	N/A
Recruiting	`NCT05757817` - Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae	N/A
Active, not recruiting	`NCT02586207` - Pembrolizumab in Combination With CRT for LA-SCCHN	Phase 1
Completed	`NCT01108042` - TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer	Phase 1/Phase 2
Completed	`NCT03342378` - PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients
Terminated	`NCT01066741` - Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer	Phase 3
Completed	`NCT03418792` - Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx	N/A
Recruiting	`NCT06088381` - Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)	Phase 2
Recruiting	`NCT05686226` - E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers	Phase 2

NCT number	NCT03416153
Study type	Interventional
Source	University of Michigan Rogel Cancer Center
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	May 21, 2018
Completion date	May 2024

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms